MyoGene Bio is a biotech startup dedicated to developing cutting edge therapies for muscle diseases. Our first approach is a gene editing therapy for Duchenne muscular dystrophy that uses state-of-the-art technology to remove mutations that cause Duchenne for around half of all patients. We were spun out of UCLA in 2019.